


Incepta Pharmaceuticals Email Formats
Pharmaceutical Manufacturing • 40 Shahid Tajuddin Ahmed Sarani Tejgaon I/A, Dhaka, Bangladesh • 2001-5000 Employees
Incepta Pharmaceuticals Email Formats
Incepta Pharmaceuticals uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 45.6% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 22.3% |
{first name}@company.com | john@company.com | 15.1% |
{first name}{last name}@company.com | johndoe@company.com | 9.8% |
{first name}_{last name}@company.com | john_doe@company.com | 7.2% |
Key Contacts at Incepta Pharmaceuticals
Abdul Muktadir
Chairman And Managing Director
Arefin Ahmed
Executive Director
Ehsan Aziz
Executive Director, Marketing
Nasreen Jahan
Executive Director Of Quality
Motiul Islam
Executive Director, Engineering
Md Mahbubul Karim
Executive Director
M Zillur Rahman
Executive Director, Production
Mohammad Mamun
Executive Director
Shahnaz Parveen
Executive Director, Production
Md Mazadul Islam
Chief Executive Officer
Company overview
| Headquarters | 40 Shahid Tajuddin Ahmed Sarani Tejgaon I/A, Dhaka, 1208, BD |
| Phone number | +88028891688703 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Generic Drug Products And Vaccines |
| Founded | 1999 |
| Employees | 2001-5000 |
| Socials |
About Incepta Pharmaceuticals
Incepta Pharmaceuticals Ltd. is a leading pharmaceutical company in Bangladesh established in the year 1999. The company has a very big manufacturing facility located at Savar and Dhamrai, 35 and 53 kilometer away respectively from the center of the capital city Dhaka. The company produces various types of dosage forms which include tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, nasal sprays, eye drops, creams, ointments, lotions, gels, prefilled syringes, liquid filled hard gelatin capsules, lyophilized injections, human vaccine etc. Since its inception, Incepta has been launching new and innovative products in order to fulfill unmet demand of the medical community. The focus has been to bring more new technologically advanced molecules to this country. The company specializes in value added high technology dosage forms like sustained release tablets, quick mouth dissolving tablets, effervescent tablets, barrier coated delayed release tablets, prefilled syringe products, Insulin and Insulin analogue and biological products, among others . It has established a modern research and development laboratory for the development of new, advanced dosage forms for various drugs and devices like poorly soluble drugs, dry powder inhalers, coated pellets, modified release products, taste masked preparation etc. Incepta has a very competent sales team, which promotes the specialties throughout the country. The company virtually covers every single corner of the rural as well as urban area of Bangladesh. It has its own large distribution network having 23 depots all over the country. The company has a clear vision to become a leading research based dosage form manufacturing company with global presence within a short period of time. With this view in mind the company started to expand its business in overseas markets. Currently Incepta exports to 68 different countries around the world.
Employees by Management Level
Total employees: 2001-5000
Seniority
Employees
Employees by Department
Incepta Pharmaceuticals has 1,089 employees across 17 departments.
Departments
Number of employees
Funding Data
Incepta Pharmaceuticals has never raised funding before.
Incepta Pharmaceuticals Tech Stack
Discover the technologies and tools that power Incepta Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Web servers
CDN
Security
JavaScript libraries
Programming languages
Font scripts
SSL/TLS certificate authorities
Analytics
Video players
UI frameworks
JavaScript graphics
Frequently asked questions
4.8
40,000 users



